Metropolitan Life Insurance Company (MetLife)’s Gevo GEVO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio GEVO Stock Details GEVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,246	Closed	-$1.73K	–	850
2024 Q1	$1.73K	Sell	2,246 -5,684	-72%	-$4.94K	﹤0.01%	2292
2023 Q4	$9.2K	Sell	7,930 -5,217	-40%	-$5.96K	﹤0.01%	2205
2023 Q3	$15.6K	Buy	13,147 +2,499	+23%	+$3.69K	﹤0.01%	2006
2023 Q2	$16.2K	Hold	10,648	–	–	﹤0.01%	2043
2023 Q1	$16.4K	Sell	10,648 -1,174	-10%	-$2.22K	﹤0.01%	1981
2022 Q4	$22.5K	Hold	11,822	–	–	﹤0.01%	1951
2022 Q3	$27K	Buy	11,822 +3,664	+45%	+$10.2K	﹤0.01%	1855
2022 Q2	$19.2K	Sell	8,158 -4,367	-35%	-$16K	﹤0.01%	2068
2022 Q1	$58.6K	Sell	12,525 -38,341	-75%	-$147K	﹤0.01%	1509
2021 Q4	$218K	Buy	50,866 +3,973	+8%	+$24.3K	﹤0.01%	1976
2021 Q3	$311K	Sell	46,893 -7,007	-13%	-$43.4K	﹤0.01%	1746
2021 Q2	$392K	Buy	+53,900	New	+$394K	0.01%	1686

Other funds holding GEVO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TCM

Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s GEVO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Gevo (GEVO) in Q2 2024, closing a stake of 2,246 shares — an estimated $1.73K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in GEVO in Q2 2021 and held it in 12 quarters. The position peaked at $392K in Q2 2021. 124 funds tracked by Wall St. Rank hold GEVO as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Gevo position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,246 Gevo shares in Q2 2024, an estimated $1.73K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Gevo in Q2 2021 and held it in 12 quarters.
Metropolitan Life Insurance Company (MetLife)'s Gevo position peaked at $392K in Q2 2021.
124 funds tracked by Wall St. Rank held Gevo as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.